Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Fish-oil supplementation in pregnancy, child metabolomics and asthma risk

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. The urine microbiome - Contamination or a novel paradigm?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Systems Signatures Reveal Unique Remission-path of Type 2 Diabetes Following Roux-en-Y Gastric Bypass Surgery

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Antibiotic exposure in infancy and development of BMI and body composition in childhood

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Whole Genome Sequencing Identifies CRISPLD2 as a Lung Function Gene in Children with asthma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Infant airway microbiota and topical immune perturbations in the origins of childhood asthma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Environmental and Genetic Determinants of Serum 25(OH)-Vitamin D Levels during Pregnancy and Early Childhood

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. A Trans-ancestral Meta-Analysis of Genome-Wide Association Studies Reveals Loci Associated with Childhood Obesity

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: We recently demonstrated that maternal dietary supplementation with fish oil-derived n-3 long-chain polyunsaturated fatty acids (n-3 LCPUFAs) during pregnancy reduces the risk of asthma in the offspring but the mechanisms involved are unknown.

METHODS: Here we investigated potential metabolic mechanisms using untargeted liquid chromatography-mass spectrometry-based metabolomics on 577 plasma samples collected at age 6 months in the offspring of mothers participating in the n-3 LCPUFA randomized controlled trial. First, associations between the n-3 LCPUFA supplementation groups and child metabolite levels were investigated using univariate regression models and data-driven partial least square discriminant analyses (PLS-DA). Second, we analyzed the association between the n-3 LCPUFA metabolomic profile and asthma development using Cox-regression. Third, we conducted mediation analyses to investigate whether the protective effect of n-3 LCPUFA on asthma was mediated via the metabolome.

FINDINGS: The univariate analyses and the PLS-DA showed that maternal fish oil supplementation affected the child's metabolome, especially with lower levels of the n-6 LCPUFA pathway-related metabolites and saturated and monounsaturated long-chain fatty acids-containing compounds, lower levels of metabolites of the tryptophan pathway, and higher levels of metabolites in the tyrosine and glutamic acid pathway. This fish oil-related metabolic profile at age 6 months was significantly associated with a reduced risk of asthma by age 5 and the metabolic profile explained 24% of the observed asthma-protective effect in the mediation analysis.

INTERPRETATION: Several of the observed pathways may be involved in the asthma-protective effect of maternal n-3 LCPUFA supplementation and act as mediators between the intervention and disease development.

FUNDING: COPSAC is funded by private and public research funds all listed on www.copsac.com.

OriginalsprogEngelsk
TidsskriftEBioMedicine
Vol/bind46
Sider (fra-til)399-410
Antal sider12
DOI
StatusUdgivet - aug. 2019

ID: 57877493